Treatment of migraine: Present and future

被引：0
作者：
Massiou, H. [1 ]
机构：
[1] Hop Lariboisiere, AP HP, Serv Neurol, F-75475 Paris 10, France
来源：
REVUE DE MEDECINE INTERNE | 2010年 / 31卷 / 06期
关键词：
Migraine; Treatment; Triptans; CGRP receptor antagonists; CONTROLLED-TRIAL; RECEPTOR ANTAGONIST; 5-HT1B/1D AGONISTS; MEDICATION-OVERUSE; TRIPTANS; CRITERIA;
D O I：
10.1016/j.revmed.2009.12.009
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：399 / 402
页数：4
相关论文
共 17 条
  • [1] [Anonymous], 2003, REV NEUROL, V159, P126
  • [2] Defeating migraine pain with triptans: A race against the development of cutaneous allodynia
    Burstein, R
    Collins, B
    Jakubowski, M
    [J]. ANNALS OF NEUROLOGY, 2004, 55 (01) : 19 - 26
  • [3] Randomized, controlled trial of telcagepant for the acute treatment of migraine
    Connor, K. M.
    Shapiro, R. E.
    Diener, H. -C.
    Lucas, S.
    Kost, J.
    Fan, X.
    Fei, K.
    Assaid, C.
    Lines, C.
    Ho, T. W.
    [J]. NEUROLOGY, 2009, 73 (12) : 970 - 977
  • [4] Opiate-induced persistent pronociceptive trigeminal neural adaptations: potential relevance to opiate-induced medication overuse headache
    De Felice, M.
    Porreca, F.
    [J]. CEPHALALGIA, 2009, 29 (12) : 1277 - 1284
  • [5] Utility of topiramate for the treatment of patients with chronic migraine in the presence or absence of acute medication overuse
    Diener, H-C
    Dodickz, D. W.
    Goadsby, P. J.
    Bigal, M. E.
    Bussone, G.
    Silberstein, S. D.
    Mathew, N.
    Ascher, S.
    Morein, J.
    Hulihan, J. F.
    Biondi, D. M.
    Greenberg, S. J.
    [J]. CEPHALALGIA, 2009, 29 (10) : 1021 - 1027
  • [6] Consensus statement:: Cardiovascular safety profile of triptans (5-HT1B/1D agonists) in the acute treatment of migraine
    Dodick, D
    Lipton, RB
    Martin, V
    Papademetriou, V
    Rosamond, W
    MaassenVanDenBrink, A
    Loutfi, H
    Welch, KM
    Goadsby, PJ
    Hahn, S
    Hutchinson, S
    Matchar, D
    Silberstein, S
    Smith, TR
    Purdy, RA
    Saiers, J
    [J]. HEADACHE, 2004, 44 (05): : 414 - 425
  • [7] CGRP-receptor antagonism in migraine treatment
    Edvinsson, Lars
    [J]. LANCET, 2008, 372 (9656) : 2089 - 2090
  • [8] Oral triptans (serotonin 5-HT1B/1D agonists) in acute migraine treatment:: a meta-analysis of 53 trials
    Ferrari, MD
    Roon, KI
    Lipton, RB
    Goadsby, PJ
    [J]. LANCET, 2001, 358 (9294) : 1668 - 1675
  • [9] Early vs. non-early intervention in acute migraine - 'Act when Mild (AwM)'. A double-blind, placebo-controlled trial of almotriptan
    Goadsby, P. J.
    Zanchin, G.
    Geraud, G.
    de Klippel, N.
    Diaz-Insa, S.
    Gobel, H.
    Cunha, L.
    Ivanoff, N.
    Falques, M.
    Fortea, J.
    [J]. CEPHALALGIA, 2008, 28 (04) : 383 - 391
  • [10] Randomized controlled trial of an oral CGRP receptor antagonist, MK-0974, in acute treatment of migraine
    Ho, T. W.
    Mannix, L. K.
    Fan, X.
    Assaid, C.
    Furtek, C.
    Jones, C. J.
    Lines, C. R.
    Rapoport, A. M.
    [J]. NEUROLOGY, 2008, 70 (16) : 1304 - 1312
12